AVITA Medical Inc. (RCEL): Market Cap to Revenue

Symbol and logo of brand AVITA Medical Inc. (RCEL)

AVITA Medical, Inc. (RCEL) aims to secure a dominant position in the US hospital sector by scaling its regenerative technologies. The P/S time series illustrates the progress of this trajectory, with the latest mark standing at 5.90. However, expansion into aesthetic surgery and the struggle for B2B client loyalty in burn centers remain significant challenges for the business's capitalization.

RCEL AVITA Medical Inc. P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for AVITA Medical, Inc (RCEL)

- share price and consensus valuation forecast:
General company analysis:RCEL avitamedical.com
Core merchandise of AVITA Medical, Inc.

To minimize the risk of overpaying for the asset, investors should compare the market capitalization of AVITA Medical, Inc. (RCEL) with annual sales volume, utilizing revenue multiple dynamics to identify overbought zones. The high operational efficiency of RECELL systems in regenerative medicine makes this metric a key measure of business value, where deviations from historical averages signal a potential correction should the expansion of innovative technologies slow down.

Competitors of AVITA Medical, Inc.

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Biosciences) - P/S Multiple|InMode Ltd (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics Inc. SRDX|P/S Multiple SENS (Senseonics Holdings)|P/S Multiple neuropace.com NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|OM (Outset) - Market Cap to Revenue|Electromed - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR, Inc.) - P/S Multiple|Price to Sales Profound Medical Corporation PROF|Price-to-Revenue Ratio Baird Medical Investment (BDMD)|edap-tms.com (EDAP) - Price-to-Revenue Multiple|Apyx Medical Corporation - Market Cap to Revenue|P/S Multiple IceCure Medical Ltd. ICCM|Pulmonx Corp. - P/S Multiple|Price-to-Revenue Coefficient TELA Bio, Inc. TELA|cytosorbents.com (CTSO) - Price-to-Revenue Ratio|Price-to-Sales Ratio SRTS (Sensus Healthcare Inc)|Price-to-Revenue Ratio Zynex Inc|Market Cap to Revenue electroCore Medical (ECOR)|P/S Multiple RBOT|IINN - Price to Sales|Price-to-Revenue Ratio SeaStar Medical ICU|IRIX: Market Cap to Revenue Ratio|INBS: Market Cap to Revenue|Beyond Air, Inc. - Market Cap to Sales Volume|PFSA: P/S Multiple|STRATA Skin Sciences, Inc. (SSKN) - P/S Multiple|Market Cap to Revenue GCTK|Price-to-Revenue Ratio NAOV|P/S Multiple VERO|Price-to-Revenue Coefficient Nuwellis Corp|Aethlon Medical - Market Cap to Revenue|Market Cap to Sales Volume ASXC (Asensus Surgical Inc)|Avinger - P/S Multiple|BSGM - P/S Multiple|CUTR (Cutera, Inc) - Market Cap to Revenue|Know Labs Corporation - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Inari Medical, Inc.|Market Cap to Revenue nevro.com (NVRO)|P/S Multiple RSLS|SILK - Price to Sales